online randomisation tool (Metronomia Clinical Research GmbH)
Structured Review

Online Randomisation Tool, supplied by Metronomia Clinical Research GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/online+randomisation+tool/online+randomisation+tool/pmc07521913-140-25-10
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial"
Article Title: Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
Journal: The Lancet Rheumatology
doi: 10.1016/S2665-9913(20)30341-6
Figure Legend Snippet: Baseline demographic and clinical characteristics
Techniques Used: Control, Biomarker Discovery, Medications
Figure Legend Snippet: Treatment assignment, clinical characteristics, and causes of death
Techniques Used: Control
Related Articles
Control:Article Title: Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial Article Snippet: The Biomarker Discovery:Article Title: Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial Article Snippet: The Medications:Article Title: Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial Article Snippet: The |